Citadel Advisors - GENETIC TECHNOLOGIES LTD ownership

GENETIC TECHNOLOGIES LTD's ticker is GENE and the CUSIP is 37185R307. A total of 13 filers reported holding GENETIC TECHNOLOGIES LTD in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Citadel Advisors ownership history of GENETIC TECHNOLOGIES LTD
ValueSharesWeighting
Q1 2023$12,060
-70.6%
10,308
-71.5%
0.00%
Q2 2022$41,000
-70.7%
36,117
-49.2%
0.00%
Q1 2022$140,000
-30.7%
71,158
-33.7%
0.00%
Q4 2021$202,000
-27.6%
107,355
+18.7%
0.00%
Q3 2021$279,000
-26.6%
90,472
+1.3%
0.00%
Q2 2021$380,000
-49.1%
89,352
-50.1%
0.00%
Q1 2021$746,000
+73.5%
178,890
+49.6%
0.00%
Q4 2020$430,000
+198.6%
119,573
+188.1%
0.00%
Q3 2020$144,00041,5000.00%
Other shareholders
GENETIC TECHNOLOGIES LTD shareholders Q2 2022
NameSharesValueWeighting ↓
Scarborough Advisors, LLC 10,638$8,1130.00%
RHUMBLINE ADVISERS 18,700$14,3780.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
MORGAN STANLEY 87,656$66,8460.00%
TWO SIGMA SECURITIES, LLC 15,844$12,0830.00%
View complete list of GENETIC TECHNOLOGIES LTD shareholders